Pen Needles Market Size, Share & Trends Analysis Report By Type (Standard Pen Needles, Safety Pen Needles), By Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm), By Mode of Purchase (Retail, Non-retail), By Therapy, By Region, And By Segment Forecasts, 2024-2031
Segmentation of Pen Needles Market-
Pen Needles Market By Type-
- Standard Pen Needles
- Safety Pen Needles
Pen Needles Market By Length-
- 4 mm Pen Needle
- 5 mm Pen Needle
- 6 mm Pen Needle
- 8 mm Pen Needle
- 10 mm Pen Needle
- 12 mm Pen Needle
Pen Needles Market By Mode of Purchase-
- Retail
- Non-retail
Pen Needles Market By Therapy-
- Insulin
- Glucagon-Like Peptide-1
- Growth Hormone
- Other therapies
Pen Needles Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pen Needles Market Snapshot
Chapter 4. Global Pen Needles Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Product Type:
5.2.1. Standard pen needles
5.2.2. Safety pen needles
Chapter 6. Market Segmentation 2: By Length Estimates & Trend Analysis
6.1. By Length & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Length:
6.2.1. 4mm
6.2.2. 5mm
6.2.3. 6mm
6.2.4. 8mm
6.2.5. 10mm
6.2.6. 12mm
Chapter 7. Market Segmentation 3: By Mode of Purchase Estimates & Trend Analysis
7.1. By Mode of Purchase & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Mode of Purchase:
7.2.1. Retail
7.2.2. Non-retail
Chapter 8. Market Segmentation 4: By Therapy Estimates & Trend Analysis
8.1. By Product Type & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Therapy:
8.2.1. Insulin therapy
8.2.2. Glucagon-like Peptide-1 (GLP-1) therapy
8.2.3. Growth hormone therapy
8.2.4. Other therapies
Chapter 9. Pen Needles Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Product Type, 2023-2031
9.1.2. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.1.3. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.1.4. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.1.5. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By country, 2023-2031
9.1.5.1. U.S.
9.1.6. Canada
9.2. Europe
9.2.1. Europe Pen Needles Market revenue (US$ Million) By Product Type, 2023-2031
9.2.2. Europe Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.2.3. Europe Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.2.4. Europe Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.2.5. Europe Pen Needles Market revenue (US$ Million) By country, 2023-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Pen Needles Market revenue (US$ Million) By Product Type, 2023-2031
9.3.2. Asia Pacific Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.3.3. Asia Pacific Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.3.4. Asia Pacific Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.3.5. Asia Pacific Pen Needles Market revenue (US$ Million) By country, 2023-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Pen Needles Market revenue (US$ Million) By Product Type, 2023-2031
9.4.2. Latin America Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.4.3. Latin America Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.4.4. Latin America Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.4.5. Latin America Pen Needles Market revenue (US$ Million) By country, (US$ Million) 2023-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Pen Needles Market revenue (US$ Million) By Product Type, (US$ Million)
9.5.2. Middle East & Africa Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.5.3. Middle East & Africa Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.5.4. Middle East & Africa Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.5.5. Middle East & Africa Pen Needles Market revenue (US$ Million) By country, (US$ Million) 2023-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Becton, Dickinson and Company (US)
10.2.2. Novo Nordisk A/S (Denmark)
10.2.3. Ypsomed Holding AG (Switzerland)
10.2.4. B. Braun Melsungen AG (Germany)
10.2.5. Owen Mumford (UK)
10.2.6. Terumo Corporation (Japan)
10.2.7. Nipro Corporation (Japan) Allison Medical (US)
10.2.8. AdvaCare Pharma (US)
10.2.9. Berpu Medical Technology (China)
10.2.10. ARKRAY (Japan), GlucoRx (UK)
10.2.11. HTL-STREFA (Poland)
10.2.12. UltiMed, (US)
10.2.13. Hindustan Syringes and Medical Devices (India)
10.2.14. Artsana Group (Italy)
10.2.15. PromiseMed Diabetes Care (Canada)
10.2.16. Montmed (Canada)
10.2.17. Trividia Health (US)
10.2.18. VOGT Medical Vertrieb (Germany)
10.2.19. Van Heek Medical (Netherlands)
10.2.20. Simple Diagnostics (US)
10.2.21. Iyon (Turkey)
10.2.22. Links Medical Products (US)
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Pen Needles Market Size is valued at USD 1.66 Bn in 2024 and is predicted to reach USD 3.43 Bn by the year 2031
Pen Needles Market is expected to grow at a 10.95% CAGR during the forecast period for 2024-2031.
Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK),